Jeff Landau

Jeff Landau is a seasoned biopharmaceutical executive with over 20 years of experience in corporate development, corporate strategy, and new product strategy and planning.13 He currently serves as the Senior Vice President, Head of Strategy and Chief Business Officer at CytomX Therapeutics.23

Professional Background

At CytomX Therapeutics, Landau is responsible for:

• Partnering
• License and acquisition
• Corporate strategy
• Pipeline and new product planning
• Alliance and project management1

Prior to joining CytomX, Landau held several notable positions:

• Senior Vice President of Corporate Development, Commercial, and New Product Strategy at Catalyst Biosciences, Inc.
• Corporate development and global product and pipeline strategy roles at Threshold Pharmaceuticals and Onyx Pharmaceuticals (acquired by Amgen)1

Education

Landau's educational background includes:

• M.B.A. from Stanford Graduate School of Business
• B.S. with honors in biochemistry/biotechnology from Virginia Polytechnic Institute1

Board Memberships

In addition to his role at CytomX, Landau serves on the Board of Directors for:

• California Life Sciences (CLS)25
• Sunshine BIO4

Jeff Landau's LinkedIn username is jeff-landau-9466ba3, as mentioned in the query.4